BRITTANY SASSO: Open Payments
NPI 1487272563 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 22 payments from 10 companies in 2025. Trend: 2023 $699 · 2024 $638 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 6 | $108 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Actelion Pharmaceuticals US, Inc. | 3 | $75 |
| Lilly USA, LLC | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Amgen Inc. | 2 | $29 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: FUROSCIX, LEQVIO, OPSUMIT, OPSYNVI, ZEPBOUND, REPATHA, CAMZYOS, ELIQUIS.
Industry payments across NY — which companies pay providers there.
